Graphenea has opened a branch in the USA to assist more immediate service of the company's North American customers.
The US branch, Graphenea Inc, is based in Cambridge (Boston), MA, due to the close relation that the company has with research giants Massachusetts Institute of Technology (MIT) and Harvard.
Apart from developing collaborative projects with those two partners, and acting as a sales outpost for its renown high-quality graphene, Graphenea Inc will set up an “Applications Laboratory” to help develop custom graphene materials.
“The US outpost of Graphenea will continue and enhance the research excellence of the company, with planned hirings of full time R&D and Business Development personnel”, says Jesus de la Fuente, CEO of Graphenea. “The most pronounced application directions that we will pursue will be advanced polymers, thermal interface materials, energy storage, and (bio)sensors.”
Graphenea, headquartered at the nanotechnology cluster CIC nanoGune in San Sebastian, Spain, was established in 2010, and has since grown to be one of the world's largest providers of graphene. Graphenea employs 12 people and exports graphene materials to 52 countries. The company has focused on developing the CVD growth and transfer method, reaching a consistently high quality of its graphene films that researchers can rely on.
Graphenea employs a team of skilled laboratory staff who have brought graphene transfer techniques to a new level, offering the same high quality films on any substrate. Following the trends in cutting-edge research, Graphenea also produces chemically exfoliated graphene. Graphenea partners with large multinationals to develop custom graphene materials for their applications.
Its research agility and ability to keep pace with the progress of graphene science and technology has allowed Graphenea to become the largest graphene supplier in the Graphene Flagship, a ten year project of the European Commission worth a billion euros. The company keeps a close relation with the world's leading scientists, regularly publishing scientific articles of the highest level.